Analysis of the Human c-myc Gene Replication Origin

人类c-myc基因复制起点分析

• 批准号: 7032445
• 负责人: Michael LEFFAK
• 金额: $ 27.82万
• 依托单位: WRIGHT STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1996
• 资助国家: 美国
• 起止时间: 1996-03-01 至 2009-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7032445
• 关键词: DNA footprinting; DNA replication; DNA replication origin; HeLa cells; X ray crystallography; Xenopus; animal extract; binding sites; chemical structure; chemical structure function; chromatin; chromatin immunoprecipitation; chromosomes; genetic manipulation; genetic models; genetic transcription; immunologic techniques; intermolecular interaction; mutant; nucleic acid sequence; nucleic acid structure; protooncogene; recombinase; transcription factor; yeasts

DESCRIPTION (provided by applicant): DNA replication is essential for cell proliferation, and is under strict surveillance since abnormal replication can lead to genomic instability, tumor formation or apoptosis. Drugs that target the process of replication are central to cancer chemotherapy, and insight into the control of replication may lead to new treatment strategies. The primary cell cycle control of replication occurs at replicators and replication origins, where the initiation of DNA synthesis depends on the assembly of multiprotein complexes. The human c-myc replicator will be used as a model system. We previously identified the c-myc replicator and demonstrated its activity at the endogenous c-myc locus, in transfected plasmids in human cells, in plasmids replicated in vitro, and at an ectopic site in the HeLa genome. Recently, we used the yeast FLP recombinase to target mutagenized c-myc replicator constructs to a specific genomic site and identify sequences essential for origin activity. Using one of these sequences as bait in a yeast one-hybrid assay we discovered the c-myc DNA unwinding element binding protein DUE-B. We will continue to use the FLP recombinase system to generate clonal human cell lines with targeted integration of c-myc replicator constructs. We will test several aspects of a model in which epigenetic factors specify replication initiation sites and the DUE-B protein is involved in the loading of DNA repair proteins at presumptive replication forks. Aim 1 will alter the structure of the c-myc replicator by methylation or substitution mutagenesis; Aim 2 will assess the relationship between protein binding and replicator activity. All replicator mutants will be analyzed at the same chromosomal acceptor site. Replicator activity and structure will be analyzed by quantitative PCR, DNase digestion, and chromatin immunoprecipitation. In Aim 3 we will characterize the DUE-B protein and its role in DNA replication using physical, biochemical and immunological methods.

描述（由申请人提供）： DNA复制对于细胞增殖是必不可少的，并且受到严格的监视，因为异常复制可导致基因组不稳定、肿瘤形成或凋亡。靶向复制过程的药物是癌症化疗的核心，对复制控制的深入了解可能会导致新的治疗策略。复制的主要细胞周期控制发生在复制子和复制起点，其中DNA合成的起始取决于多蛋白复合物的组装。 人类c-myc复制子将被用作模型系统。我们以前确定了c-myc复制子，并证明了其在内源性c-myc基因座的活性，在转染的质粒在人类细胞中，在体外复制的质粒，并在HeLa基因组中的异位位点。最近，我们使用酵母FLP重组酶将诱变的c-myc复制子构建体靶向到特定的基因组位点，并鉴定对起源活性至关重要的序列。在酵母单杂交试验中使用这些序列之一作为诱饵，我们发现了c-myc DNA解旋元件结合蛋白DUE-B。 我们将继续使用FLP重组酶系统来产生具有c-myc复制子构建体的靶向整合的克隆人细胞系。 我们将测试一个模型的几个方面，其中表观遗传因素指定复制起始位点和DUE-B蛋白参与加载DNA修复蛋白在假定的复制叉。目的1将通过甲基化或取代诱变改变c-myc复制子的结构;目的2将评估蛋白质结合与复制子活性之间的关系。将在相同的染色体受体位点分析所有复制子突变体。将通过定量PCR、DNA酶消化和染色质免疫沉淀分析复制子活性和结构。在目标3中，我们将使用物理，生物化学和免疫学方法表征DUE-B蛋白及其在DNA复制中的作用。